Infinitus (China) has two production bases respectively in Xinhui, Guangdong and Yingkou, Liaoning. Infinitus Xinhui Production Base covers an area of 300 mu (about 200,000 square metres) with a total investment of over RMB 3 billion. Infinitus Yingkou Production Base covers an area of 500 mu (about 350,000 square metres) with a total investment of RMB 1.5 billion for the initial phase.
Committed to providing high-quality Chinese herbal health products to the public, Infinitus (China) invests hundreds of millions of RMB in R&D and technology enhancement every year, and cooperates with world-renowned universities and research institutions , including Cambridge University, Stanford University, Cornell University, the French National Center for Scientific Research-Paris Diderot University, Hong Kong University of Science and Technology, China Academy of Chinese Medical Sciences, Chinese Academy of Sciences Shanghai Institute of Materia Medica, and Oilcrops Research Institute of Chinese Academy of Agricultural Sciences. It also owns a number of core independent intellectual property rights and leads in the research of compound polysaccharides technology.
In terms of quality management, Infinitus (China) has developed and implemented the Outstanding Supply Chain Management Model and got certified to ISO9001:2015, FSSC22000:V3, HACCP and ISO22716:2007(E)/GMPC(US)2008. It has also been accredited as a National High-Tech Enterprise of China with 118 products in 43 categories accredited as High-Tech Products in Guangdong Province. It has been honoured by the China Food Safety Annual Conference for 15 consecutive years. And the Infinitus Product Inspection Centre in Xinhui Production Base and the Technology Centre of Infinitus Yingkou Production Base have both been certified by the China National Accreditation Service for Conformity Assessment (CNAS) as the Laboratories of National Accreditation. Infinitus Xinhui Production Base also passed the Proficiency Testing for Food Chemistry of the Food Analysis Performance Assessment Scheme (FAPAS) in the UK.
Adhering to the core values of "Si Li Ji Ren" and the corporate mission of "advocating the premium Chinese health regimen and nurturing healthier lives with balance, affluence and harmony", Infinitus (China) has forged distinctive health philosophy, differentiated corporate competitiveness and positive brand reputation with widespread public recognition. In 2017, the brand value of "Infinitus" was rated at RMB 65.869 billion by the World Brand Lab, ranking 45th among China's 500 Most Valuable Brands. Moreover, it was shortlisted as a Best Employer in Asia and a Best Employer in China by the global leading HR consulting institute Aon Hewitt for several times and claimed the title of "Best Company to Work For in China" for three times.
While developing from strength to strength, Infinitus (China) has always been shouldering its corporate social responsibility in six aspects, including health, quality, employees, partners, environment and community. With continuous innovative practices, it strives to create value for stakeholders and itself. In 2017, Infinitus (China) actively responded to the Sustainable Development Goals (SDGs) launched by the United Nations, and established its SDGs initiative framework with focus on health, people, Earth and community. So far, it has donated a total of 21 primary schools under the name "Infinitus" in underdeveloped regions of the Chinese mainland. And it has carried out several philanthropy activities such as "Infinitus World Walking Day" and "Health Maintenance Promotion for Families". In 2012, the Company donated RMB 20 million to set up the Si Li Ji Ren Foundation, which has launched multiple programmes including the Si Li Ji Ren Education Dream Support Programme. So far, it has made accumulated donation worth over RMB 200 million.
